Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 54 entries
Sorted by: Best Match Show Resources per page
Ultrasonic imaging in air using fan-beam tomography and electrostatic transducers.

Ultrasonics

Ingleby P, Wright WM.
PMID: 12159992
Ultrasonics. 2002 May;40(1):507-11. doi: 10.1016/s0041-624x(02)00173-7.

Air-coupled ultrasonic capacitance transducers operating at frequencies of up to 1 MHz have been employed in a fan-beam configuration for the cross-sectional tomographic imaging of temperature fields and flow fields in air, and the location of solid objects. Separate...

Cite
Ingleby P, Wright WM. Ultrasonic imaging in air using fan-beam tomography and electrostatic transducers. Ultrasonics. 2002;40(1):507-11doi: 10.1016/s0041-624x(02)00173-7.
Ingleby, P., & Wright, W. M. (2002). Ultrasonic imaging in air using fan-beam tomography and electrostatic transducers. Ultrasonics, 40(1), 507-11. https://doi.org/10.1016/s0041-624x(02)00173-7
Ingleby, Paul, and Wright, William M D. "Ultrasonic imaging in air using fan-beam tomography and electrostatic transducers." Ultrasonics vol. 40,1 (2002): 507-11. doi: https://doi.org/10.1016/s0041-624x(02)00173-7
Ingleby P, Wright WM. Ultrasonic imaging in air using fan-beam tomography and electrostatic transducers. Ultrasonics. 2002 May;40(1):507-11. doi: 10.1016/s0041-624x(02)00173-7. PMID: 12159992.
Copy Download .nbib Format: NLM
Metabolic Profiling and Post-harvest Behavior of "Dottato" Fig (.

Frontiers in plant science

Allegra A, Gallotta A, Carimi F, Mercati F, Inglese P, Martinelli F.
PMID: 30233636
Front Plant Sci. 2018 Sep 05;9:1321. doi: 10.3389/fpls.2018.01321. eCollection 2018.

Fig fruits are usually highly sensitive to some physiopathological disorders during post-harvest life, such as softening and skin cracking. Indeed, the use of edible coating (EC) has been evaluated in several fruit crops to reduce fruit post-harvest transpiration and...

Cite
Allegra A, Gallotta A, Carimi F, et al. Metabolic Profiling and Post-harvest Behavior of "Dottato" Fig (. Front Plant Sci. 2018;9:1321doi: 10.3389/fpls.2018.01321.
Allegra, A., Gallotta, A., Carimi, F., Mercati, F., Inglese, P., & Martinelli, F. (2018). Metabolic Profiling and Post-harvest Behavior of "Dottato" Fig (. Frontiers in plant science, 91321. https://doi.org/10.3389/fpls.2018.01321
Allegra, Alessio, et al. "Metabolic Profiling and Post-harvest Behavior of "Dottato" Fig (." Frontiers in plant science vol. 9 (2018): 1321. doi: https://doi.org/10.3389/fpls.2018.01321
Allegra A, Gallotta A, Carimi F, Mercati F, Inglese P, Martinelli F. Metabolic Profiling and Post-harvest Behavior of "Dottato" Fig (. Front Plant Sci. 2018 Sep 05;9:1321. doi: 10.3389/fpls.2018.01321. eCollection 2018. PMID: 30233636; PMCID: PMC6134321.
Copy Download .nbib Format: NLM
From PIM1 to PI3Kδ via GSK3β: Target Hopping through the Kinome.

ACS medicinal chemistry letters

Henley ZA, Bax BD, Inglesby LM, Champigny A, Gaines S, Faulder P, Le J, Thomas DA, Washio Y, Baldwin IR.
PMID: 29057057
ACS Med Chem Lett. 2017 Sep 07;8(10):1093-1098. doi: 10.1021/acsmedchemlett.7b00296. eCollection 2017 Oct 12.

Selective inhibitors of phosphoinositide 3-kinase delta are of interest for the treatment of inflammatory diseases. Initial optimization of a 3-substituted indazole hit compound targeting the kinase PIM1 focused on improving selectivity over GSK3β through consideration of differences in the...

Cite
Henley ZA, Bax BD, Inglesby LM, et al. From PIM1 to PI3Kδ via GSK3β: Target Hopping through the Kinome. ACS Med Chem Lett. 2017;8(10):1093-1098doi: 10.1021/acsmedchemlett.7b00296.
Henley, Z. A., Bax, B. D., Inglesby, L. M., Champigny, A., Gaines, S., Faulder, P., Le, J., Thomas, D. A., Washio, Y., & Baldwin, I. R. (2017). From PIM1 to PI3Kδ via GSK3β: Target Hopping through the Kinome. ACS medicinal chemistry letters, 8(10), 1093-1098. https://doi.org/10.1021/acsmedchemlett.7b00296
Henley, Zoë A, et al. "From PIM1 to PI3Kδ via GSK3β: Target Hopping through the Kinome." ACS medicinal chemistry letters vol. 8,10 (2017): 1093-1098. doi: https://doi.org/10.1021/acsmedchemlett.7b00296
Henley ZA, Bax BD, Inglesby LM, Champigny A, Gaines S, Faulder P, Le J, Thomas DA, Washio Y, Baldwin IR. From PIM1 to PI3Kδ via GSK3β: Target Hopping through the Kinome. ACS Med Chem Lett. 2017 Sep 07;8(10):1093-1098. doi: 10.1021/acsmedchemlett.7b00296. eCollection 2017 Oct 12. PMID: 29057057; PMCID: PMC5642016.
Copy Download .nbib Format: NLM
Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? - Authors' reply.

The Lancet. Rheumatology

Rentsch CT, DeVito NJ, MacKenna B, Morton CE, Bhaskaran K, Brown JP, Schultze A, Hulme WJ, Croker R, Walker AJ, Williamson EJ, Bates C, Bacon S, Mehrkar A, Curtis HJ, Evans D, Wing K, Inglesby P, Mathur R, Drysdale H, Wong AYS, McDonald HI, Cockburn J, Forbes H, Parry J, Hester F, Harper S, Smeeth L, Douglas IJ, Dixon WG, Evans SJW, Tomlinson L, Goldacre B.
PMID: 33655224
Lancet Rheumatol. 2021 Mar;3(3):e172-e173. doi: 10.1016/S2665-9913(21)00030-8. Epub 2021 Jan 27.

No abstract available.

Cite
Rentsch CT, DeVito NJ, MacKenna B, et al. Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? - Authors' reply. Lancet Rheumatol. 2021;3(3):e172-e173doi: 10.1016/S2665-9913(21)00030-8.
Rentsch, C. T., DeVito, N. J., MacKenna, B., Morton, C. E., Bhaskaran, K., Brown, J. P., Schultze, A., Hulme, W. J., Croker, R., Walker, A. J., Williamson, E. J., Bates, C., Bacon, S., Mehrkar, A., Curtis, H. J., Evans, D., Wing, K., Inglesby, P., Mathur, R., Drysdale, H., Wong, A. Y. S., McDonald, H. I., Cockburn, J., Forbes, H., Parry, J., Hester, F., Harper, S., Smeeth, L., Douglas, I. J., Dixon, W. G., Evans, S. J. W., Tomlinson, L., & Goldacre, B. (2021). Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? - Authors' reply. The Lancet. Rheumatology, 3(3), e172-e173. https://doi.org/10.1016/S2665-9913(21)00030-8
Rentsch, Christopher T, et al. "Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? - Authors' reply." The Lancet. Rheumatology vol. 3,3 (2021): e172-e173. doi: https://doi.org/10.1016/S2665-9913(21)00030-8
Rentsch CT, DeVito NJ, MacKenna B, Morton CE, Bhaskaran K, Brown JP, Schultze A, Hulme WJ, Croker R, Walker AJ, Williamson EJ, Bates C, Bacon S, Mehrkar A, Curtis HJ, Evans D, Wing K, Inglesby P, Mathur R, Drysdale H, Wong AYS, McDonald HI, Cockburn J, Forbes H, Parry J, Hester F, Harper S, Smeeth L, Douglas IJ, Dixon WG, Evans SJW, Tomlinson L, Goldacre B. Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? - Authors' reply. Lancet Rheumatol. 2021 Mar;3(3):e172-e173. doi: 10.1016/S2665-9913(21)00030-8. Epub 2021 Jan 27. PMID: 33655224; PMCID: PMC7906669.
Copy Download .nbib Format: NLM
Trends and clinical characteristics of 57.9 million COVID-19 vaccine recipients: a federated analysis of patients' primary care records .

The British journal of general practice : the journal of the Royal College of General Practitioners

Curtis HJ, Inglesby P, Morton CE, MacKenna B, Green A, Hulme W, Walker AJ, Morley J, Mehrkar A, Bacon S, Hickman G, Bates C, Croker R, Evans D, Ward T, Cockburn J, Davy S, Bhaskaran K, Schultze A, Rentsch CT, Williamson EJ, Rowan A, Fisher L, McDonald HI, Tomlinson L, Mathur R, Drysdale H, Eggo RM, Wing K, Wong AY, Forbes H, Parry J, Hester F, Harper S, O'Hanlon S, Eavis A, Jarvis R, Avramov D, Griffiths P, Fowles A, Parkes N, Douglas IJ, Evans SJ, Smeeth L, Goldacre B.
PMID: 34750106
Br J Gen Pract. 2021 Dec 31;72(714):e51-e62. doi: 10.3399/BJGP.2021.0376. Print 2022 Jan.

BACKGROUND: On 8 December 2020 NHS England administered the first COVID-19 vaccination.AIM: To describe trends and variation in vaccine coverage in different clinical and demographic groups in the first 100 days of the vaccine rollout.DESIGN AND SETTING: With the...

Cite
Curtis HJ, Inglesby P, Morton CE, et al. Trends and clinical characteristics of 57.9 million COVID-19 vaccine recipients: a federated analysis of patients' primary care records . Br J Gen Pract. 2021;72(714):e51-e62doi: 10.3399/BJGP.2021.0376.
Curtis, H. J., Inglesby, P., Morton, C. E., MacKenna, B., Green, A., Hulme, W., Walker, A. J., Morley, J., Mehrkar, A., Bacon, S., Hickman, G., Bates, C., Croker, R., Evans, D., Ward, T., Cockburn, J., Davy, S., Bhaskaran, K., Schultze, A., Rentsch, C. T., Williamson, E. J., Rowan, A., Fisher, L., McDonald, H. I., Tomlinson, L., Mathur, R., Drysdale, H., Eggo, R. M., Wing, K., Wong, A. Y., Forbes, H., Parry, J., Hester, F., Harper, S., O'Hanlon, S., Eavis, A., Jarvis, R., Avramov, D., Griffiths, P., Fowles, A., Parkes, N., Douglas, I. J., Evans, S. J., Smeeth, L., Goldacre, B. (2022). Trends and clinical characteristics of 57.9 million COVID-19 vaccine recipients: a federated analysis of patients' primary care records . The British journal of general practice : the journal of the Royal College of General Practitioners, 72(714), e51-e62. https://doi.org/10.3399/BJGP.2021.0376
Curtis, Helen J, et al. "Trends and clinical characteristics of 57.9 million COVID-19 vaccine recipients: a federated analysis of patients' primary care records ." The British journal of general practice : the journal of the Royal College of General Practitioners vol. 72,714 (2022): e51-e62. doi: https://doi.org/10.3399/BJGP.2021.0376
Curtis HJ, Inglesby P, Morton CE, MacKenna B, Green A, Hulme W, Walker AJ, Morley J, Mehrkar A, Bacon S, Hickman G, Bates C, Croker R, Evans D, Ward T, Cockburn J, Davy S, Bhaskaran K, Schultze A, Rentsch CT, Williamson EJ, Rowan A, Fisher L, McDonald HI, Tomlinson L, Mathur R, Drysdale H, Eggo RM, Wing K, Wong AY, Forbes H, Parry J, Hester F, Harper S, O'Hanlon S, Eavis A, Jarvis R, Avramov D, Griffiths P, Fowles A, Parkes N, Douglas IJ, Evans SJ, Smeeth L, Goldacre B. Trends and clinical characteristics of 57.9 million COVID-19 vaccine recipients: a federated analysis of patients' primary care records . Br J Gen Pract. 2021 Dec 31;72(714):e51-e62. doi: 10.3399/BJGP.2021.0376. Print 2022 Jan. PMID: 34750106; PMCID: PMC8589463.
Copy Download .nbib Format: NLM
Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records .

The British journal of general practice : the journal of the Royal College of General Practitioners

Walker AJ, MacKenna B, Inglesby P, Tomlinson L, Rentsch CT, Curtis HJ, Morton CE, Morley J, Mehrkar A, Bacon S, Hickman G, Bates C, Croker R, Evans D, Ward T, Cockburn J, Davy S, Bhaskaran K, Schultze A, Williamson EJ, Hulme WJ, McDonald HI, Mathur R, Eggo RM, Wing K, Wong AY, Forbes H, Tazare J, Parry J, Hester F, Harper S, O'Hanlon S, Eavis A, Jarvis R, Avramov D, Griffiths P, Fowles A, Parkes N, Douglas IJ, Evans SJ.
PMID: 34340970
Br J Gen Pract. 2021 Oct 28;71(712):e806-e814. doi: 10.3399/BJGP.2021.0301. Print 2021 Nov.

BACKGROUND: Long COVID describes new or persistent symptoms at least 4 weeks after onset of acute COVID-19. Clinical codes to describe this phenomenon were recently created.AIM: To describe the use of long-COVID codes, and variation of use by general...

Cite
Walker AJ, MacKenna B, Inglesby P, et al. Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records . Br J Gen Pract. 2021;71(712):e806-e814doi: 10.3399/BJGP.2021.0301.
Walker, A. J., MacKenna, B., Inglesby, P., Tomlinson, L., Rentsch, C. T., Curtis, H. J., Morton, C. E., Morley, J., Mehrkar, A., Bacon, S., Hickman, G., Bates, C., Croker, R., Evans, D., Ward, T., Cockburn, J., Davy, S., Bhaskaran, K., Schultze, A., Williamson, E. J., Hulme, W. J., McDonald, H. I., Mathur, R., Eggo, R. M., Wing, K., Wong, A. Y., Forbes, H., Tazare, J., Parry, J., Hester, F., Harper, S., O'Hanlon, S., Eavis, A., Jarvis, R., Avramov, D., Griffiths, P., Fowles, A., Parkes, N., Douglas, I. J., Evans, S. J. (2021). Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records . The British journal of general practice : the journal of the Royal College of General Practitioners, 71(712), e806-e814. https://doi.org/10.3399/BJGP.2021.0301
Walker, Alex J, et al. "Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records ." The British journal of general practice : the journal of the Royal College of General Practitioners vol. 71,712 (2021): e806-e814. doi: https://doi.org/10.3399/BJGP.2021.0301
Walker AJ, MacKenna B, Inglesby P, Tomlinson L, Rentsch CT, Curtis HJ, Morton CE, Morley J, Mehrkar A, Bacon S, Hickman G, Bates C, Croker R, Evans D, Ward T, Cockburn J, Davy S, Bhaskaran K, Schultze A, Williamson EJ, Hulme WJ, McDonald HI, Mathur R, Eggo RM, Wing K, Wong AY, Forbes H, Tazare J, Parry J, Hester F, Harper S, O'Hanlon S, Eavis A, Jarvis R, Avramov D, Griffiths P, Fowles A, Parkes N, Douglas IJ, Evans SJ. Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records . Br J Gen Pract. 2021 Oct 28;71(712):e806-e814. doi: 10.3399/BJGP.2021.0301. Print 2021 Nov. PMID: 34340970; PMCID: PMC8340730.
Copy Download .nbib Format: NLM
Safety precautions to limit exposure from plague-infected patients.

JAMA

Inglesby TV, Henderson DA, O'Toole T, Dennis DT.
PMID: 11015789
JAMA. 2000 Oct 04;284(13):1648-9.

No abstract available.

Cite
Inglesby TV, Henderson DA, O'Toole T, et al. Safety precautions to limit exposure from plague-infected patients. JAMA. 2000;284(13):1648-9
Inglesby, T. V., Henderson, D. A., O'Toole, T., & Dennis, D. T. (2000). Safety precautions to limit exposure from plague-infected patients. JAMA, 284(13), 1648-9.
Inglesby, et al. "Safety precautions to limit exposure from plague-infected patients." JAMA vol. 284,13 (2000): 1648-9.
Inglesby TV, Henderson DA, O'Toole T, Dennis DT. Safety precautions to limit exposure from plague-infected patients. JAMA. 2000 Oct 04;284(13):1648-9. PMID: 11015789.
Copy Download .nbib Format: NLM
Cardiac disease 1976.

Annals of internal medicine

Oglesby P.
PMID: 970779
Ann Intern Med. 1976 Oct;85(4):520-1. doi: 10.7326/0003-4819-85-4-520.

No abstract available.

Cite
Oglesby P. Cardiac disease 1976. Ann Intern Med. 1976;85(4):520-1doi: 10.7326/0003-4819-85-4-520.
Oglesby, P. (1976). Cardiac disease 1976. Annals of internal medicine, 85(4), 520-1. https://doi.org/10.7326/0003-4819-85-4-520
Oglesby, P. "Cardiac disease 1976." Annals of internal medicine vol. 85,4 (1976): 520-1. doi: https://doi.org/10.7326/0003-4819-85-4-520
Oglesby P. Cardiac disease 1976. Ann Intern Med. 1976 Oct;85(4):520-1. doi: 10.7326/0003-4819-85-4-520. PMID: 970779.
Copy Download .nbib Format: NLM
Deep learning and 3D-DESI imaging reveal the hidden metabolic heterogeneity of cancer.

Chemical science

Inglese P, McKenzie JS, Mroz A, Kinross J, Veselkov K, Holmes E, Takats Z, Nicholson JK, Glen RC.
PMID: 28507724
Chem Sci. 2017 May 01;8(5):3500-3511. doi: 10.1039/c6sc03738k. Epub 2017 Feb 21.

Visual inspection of tumour tissues does not reveal the complex metabolic changes that differentiate cancer and its sub-types from healthy tissues. Mass spectrometry imaging, which quantifies the underlying chemistry, represents a powerful tool for the molecular exploration of tumour...

Cite
Inglese P, McKenzie JS, Mroz A, et al. Deep learning and 3D-DESI imaging reveal the hidden metabolic heterogeneity of cancer. Chem Sci. 2017;8(5):3500-3511doi: 10.1039/c6sc03738k.
Inglese, P., McKenzie, J. S., Mroz, A., Kinross, J., Veselkov, K., Holmes, E., Takats, Z., Nicholson, J. K., & Glen, R. C. (2017). Deep learning and 3D-DESI imaging reveal the hidden metabolic heterogeneity of cancer. Chemical science, 8(5), 3500-3511. https://doi.org/10.1039/c6sc03738k
Inglese, Paolo, et al. "Deep learning and 3D-DESI imaging reveal the hidden metabolic heterogeneity of cancer." Chemical science vol. 8,5 (2017): 3500-3511. doi: https://doi.org/10.1039/c6sc03738k
Inglese P, McKenzie JS, Mroz A, Kinross J, Veselkov K, Holmes E, Takats Z, Nicholson JK, Glen RC. Deep learning and 3D-DESI imaging reveal the hidden metabolic heterogeneity of cancer. Chem Sci. 2017 May 01;8(5):3500-3511. doi: 10.1039/c6sc03738k. Epub 2017 Feb 21. PMID: 28507724; PMCID: PMC5418631.
Copy Download .nbib Format: NLM
The isolation and characterization of a rhodacycle intermediate implicated in metal-catalyzed reactions of alkylidenecyclopropanes.

Angewandte Chemie (International ed. in English)

Inglesby PA, Bacsa J, Negru DE, Evans PA.
PMID: 24616050
Angew Chem Int Ed Engl. 2014 Apr 07;53(15):3952-6. doi: 10.1002/anie.201310232. Epub 2014 Mar 11.

The isolation and characterization of a rhodacycle intermediate implicated in rhodium-catalyzed reactions of alkylidenecyclopropanes (ACPs) is described. The structure of the metallacycle was unambiguously determined by X-ray crystallography and is catalytically competent in the rhodium-catalyzed carbocyclization and ene-cycloisomerization reactions...

Cite
Inglesby PA, Bacsa J, Negru DE, et al. The isolation and characterization of a rhodacycle intermediate implicated in metal-catalyzed reactions of alkylidenecyclopropanes. Angew Chem Int Ed Engl. 2014;53(15):3952-6doi: 10.1002/anie.201310232.
Inglesby, P. A., Bacsa, J., Negru, D. E., & Evans, P. A. (2014). The isolation and characterization of a rhodacycle intermediate implicated in metal-catalyzed reactions of alkylidenecyclopropanes. Angewandte Chemie (International ed. in English), 53(15), 3952-6. https://doi.org/10.1002/anie.201310232
Inglesby, Phillip A, et al. "The isolation and characterization of a rhodacycle intermediate implicated in metal-catalyzed reactions of alkylidenecyclopropanes." Angewandte Chemie (International ed. in English) vol. 53,15 (2014): 3952-6. doi: https://doi.org/10.1002/anie.201310232
Inglesby PA, Bacsa J, Negru DE, Evans PA. The isolation and characterization of a rhodacycle intermediate implicated in metal-catalyzed reactions of alkylidenecyclopropanes. Angew Chem Int Ed Engl. 2014 Apr 07;53(15):3952-6. doi: 10.1002/anie.201310232. Epub 2014 Mar 11. PMID: 24616050.
Copy Download .nbib Format: NLM
Demonstration of Preparations from Cases of Encephalitis Lethargica.

Proceedings of the Royal Society of Medicine

Da Fano C, Ingleby H.
PMID: 19980662
Proc R Soc Med. 1919;12:42-5.

No abstract available.

Cite
Da Fano C, Ingleby H. Demonstration of Preparations from Cases of Encephalitis Lethargica. Proc R Soc Med. 1919;12:42-5
Da Fano, C., & Ingleby, H. (1919). Demonstration of Preparations from Cases of Encephalitis Lethargica. Proceedings of the Royal Society of Medicine, 1242-5.
Da Fano, C, and Ingleby, H. "Demonstration of Preparations from Cases of Encephalitis Lethargica." Proceedings of the Royal Society of Medicine vol. 12 (1919): 42-5.
Da Fano C, Ingleby H. Demonstration of Preparations from Cases of Encephalitis Lethargica. Proc R Soc Med. 1919;12:42-5. PMID: 19980662; PMCID: PMC2066610.
Copy Download .nbib Format: NLM
DISCUSSION ON EPIDEMIC ENCEPHALITIS: (COMBINED MEETING.).

Proceedings of the Royal Society of Medicine

Ingleby H.
PMID: 19980670
Proc R Soc Med. 1919;12:v.

No abstract available.

Cite
Ingleby H. DISCUSSION ON EPIDEMIC ENCEPHALITIS: (COMBINED MEETING.). Proc R Soc Med. 1919;12:v
Ingleby, H. (1919). DISCUSSION ON EPIDEMIC ENCEPHALITIS: (COMBINED MEETING.). Proceedings of the Royal Society of Medicine, 12v.
Ingleby, H. "DISCUSSION ON EPIDEMIC ENCEPHALITIS: (COMBINED MEETING.)." Proceedings of the Royal Society of Medicine vol. 12 (1919): v.
Ingleby H. DISCUSSION ON EPIDEMIC ENCEPHALITIS: (COMBINED MEETING.). Proc R Soc Med. 1919;12:v. PMID: 19980670; PMCID: PMC2066604.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 54 entries